BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 36104042)

  • 1. Pregnancy costs with commercial insurance.
    Rahman M; Chen L; Daw J; Wright JD; D'Alton ME; Wen T; Friedman AM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):10143-10151. PubMed ID: 36104042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of Severe Maternal Morbidity During Pregnancy in US Commercially Insured and Medicaid Populations: An Observational Study.
    Vesco KK; Ferrante S; Chen Y; Rhodes T; Black CM; Allen-Ramey F
    Matern Child Health J; 2020 Jan; 24(1):30-38. PubMed ID: 31655962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health Service Use and Costs During Pregnancy Among Privately Insured Individuals With Congenital Heart Disease.
    Agarwal A; Duan R; Sobhani NC; Sabanayagam A; Marcus GM; Gurvitz M
    JAMA Netw Open; 2024 May; 7(5):e2410763. PubMed ID: 38739390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost sharing for oral lenvatinib among commercially insured patients.
    Liang MI; Chen L; Aviki EM; Wright JD
    Am J Manag Care; 2024 Mar; 30(3):114-117. PubMed ID: 38457819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of care for the initial management of cervical cancer in women with commercial insurance.
    Blanco M; Chen L; Melamed A; Tergas AI; Khoury-Collado F; Hou JY; St Clair CM; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Am J Obstet Gynecol; 2021 Mar; 224(3):286.e1-286.e11. PubMed ID: 32818476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of Care for the Initial Management of Ovarian Cancer.
    Bercow AS; Chen L; Chatterjee S; Tergas AI; Hou JY; Burke WM; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Obstet Gynecol; 2017 Dec; 130(6):1269-1275. PubMed ID: 29112648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Drug List Prices and Amounts Paid by Patients and Insurers.
    Yang EJ; Galan E; Thombley R; Lin A; Seo J; Tseng CW; Resneck JS; Bach PB; Dudley RA
    JAMA Netw Open; 2020 Dec; 3(12):e2028510. PubMed ID: 33295971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of observation care for commercially insured patients visiting the emergency department.
    Sabbatini AK; Wright B; Hall MK; Basu A
    Am J Emerg Med; 2018 Sep; 36(9):1591-1596. PubMed ID: 29366657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postpartum healthcare expenditures for commercially insured deliveries with and without severe maternal morbidity.
    Boulet SL; Stanhope KK; Platner M; Costley LK; Jamieson DJ
    Am J Obstet Gynecol MFM; 2024 Jan; 6(1):101225. PubMed ID: 37972925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total and out-of-pocket costs for PARP inhibitors among insured ovarian cancer patients.
    Liang MI; Chen L; Hershman DL; Hillyer GC; Huh WK; Guyton A; Wright JD
    Gynecol Oncol; 2021 Mar; 160(3):793-799. PubMed ID: 33375989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Out-of-Pocket Costs for Patients Undergoing Thyroid Surgery.
    Zheng F; Huang Y; Wright J; Kuo JH
    Ann Surg; 2022 Dec; 276(6):e937-e943. PubMed ID: 34261887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal and Neonatal Hospitalization Costs Associated With Elective Induction of Labor at Term in California, 2007-2011.
    Hersh AR; Greiner KS; Garg B; Skeith AE; Caughey AB
    Obstet Gynecol; 2020 Jul; 136(1):8-18. PubMed ID: 32541294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between maternal body mass index during pregnancy, short-term morbidity, and increased health service costs: a population-based study.
    Denison FC; Norwood P; Bhattacharya S; Duffy A; Mahmood T; Morris C; Raja EA; Norman JE; Lee AJ; Scotland G
    BJOG; 2014 Jan; 121(1):72-81; discussion 82. PubMed ID: 24102880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes, care utilization, and expenditures in adolescent pregnancy complicated by diabetes.
    Kohn JR; Rajan SS; Kushner JA; Fox KA
    Pediatr Diabetes; 2019 Sep; 20(6):769-777. PubMed ID: 31125158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Combined Influence of Maternal Medical Conditions on the Risk of Primary Cesarean Delivery.
    Fresch R; Stephens K; DeFranco E
    AJP Rep; 2024 Jan; 14(1):e51-e56. PubMed ID: 38269123
    [No Abstract]   [Full Text] [Related]  

  • 16. Maternal and infant hospitalization costs associated with hypertensive disorders of pregnancy in a California cohort
    Hersh AR; Mischkot BF; Greiner KS; Garg B; Caughey AB
    J Matern Fetal Neonatal Med; 2022 Nov; 35(21):4208-4220. PubMed ID: 33722149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal and infant hospitalization costs associated with maternal pre-pregnancy body mass index in California, 2007-2011.
    Mischkot BF; Hersh AR; Greiner KS; Garg B; Caughey AB
    J Matern Fetal Neonatal Med; 2022 Dec; 35(23):4451-4460. PubMed ID: 33261530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertensive Postpartum Admissions Among Women Without a History of Hypertension or Preeclampsia.
    Wen T; Wright JD; Goffman D; D'Alton ME; Attenello FJ; Mack WJ; Friedman AM
    Obstet Gynecol; 2019 Apr; 133(4):712-719. PubMed ID: 30870276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of Severe Maternal Morbidity in U.S. Commercially Insured and Medicaid Populations: An Updated Analysis.
    Black CM; Vesco KK; Mehta V; Ohman-Strickland P; Demissie K; Schneider D
    Womens Health Rep (New Rochelle); 2021; 2(1):443-451. PubMed ID: 34671765
    [No Abstract]   [Full Text] [Related]  

  • 20. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies.
    Mills G; Badeghiesh A; Suarthana E; Baghlaf H; Dahan MH
    Hum Reprod; 2020 Jul; 35(7):1666-1674. PubMed ID: 32535629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.